Korro Bio Inc. (KRRO)

Schlusskurs vom Vortag:

$52.77

Offen:

$52.17

24-Stunden-Volumen:

37,317

Marktkapitalisierung:

$475.32M

Einnahmen:

-

Nettoeinkommen (Verlust:

$-81.17M

KGV:

-

EPS:

-

Netto-Cashflow:

$-75.12M

1W Leistung:

-6.60%

1M Leistung:

-30.13%

6M Leistung:

+25.64%

1J Leistung:

+0.00%

1-Tages-Spanne:

$50.34

$52.90

52-Wochen-Spanne:

$34.07

$97.91

Korro Bio Inc. Stock (KRRO) Company Profile

Firmenname

Korro Bio Inc.

Sektor

Healthcare (1211)

Branche

Biotechnology (697)

Telefon

781-315-4600

Adresse

One Kendall Square, Building 600-700 Suite 6-401, Cambridge

Mitarbeiter

95

Twitter

Nächster Verdiensttermin

2024-06-11

Neueste SEC-Einreichungen

KRRO's Discussions on Twitter

Korro Bio Inc. Stock (KRRO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-03-28	Bestätigt	H.C. Wainwright	Buy
2024-02-27	Eingeleitet	BMO Capital Markets	Outperform
2023-12-04	Eingeleitet	H.C. Wainwright	Buy
2023-11-29	Eingeleitet	RBC Capital Mkts	Outperform
2023-11-10	Eingeleitet	Piper Sandler	Overweight
2023-02-15	Herabstufung	Chardan Capital Markets	Buy → Neutral
2023-02-13	Herabstufung	Cowen	Outperform → Market Perform
2021-09-22	Herabstufung	Goldman	Buy → Neutral
2021-01-27	Hochstufung	JP Morgan	Neutral → Overweight
2020-12-22	Eingeleitet	B. Riley Securities	Buy
2020-07-14	Eingeleitet	Oppenheimer	Outperform
2020-05-18	Herabstufung	JP Morgan	Overweight → Neutral
2019-10-28	Eingeleitet	Cowen	Outperform
2019-10-28	Eingeleitet	Goldman	Buy
2019-10-28	Eingeleitet	JP Morgan	Overweight

Alle ansehen

Korro Bio Inc. Aktie (KRRO) Neueste Nachrichten

Korro Bio (NASDAQ:KRRO) Price Target Lowered to $100.00 at HC Wainwright - MarketBeat

MarketBeat

BMO bullish on Korro Bio's new CMO appointment, maintains $120 stock PT - Investing.com

Investing.com

Korro Bio (NASDAQ:KRRO) Receives Outperform Rating from BMO Capital Markets - MarketBeat

MarketBeat

Korro Bio advances RNA editing candidate KRRO-110 By Investing.com - Investing.com

Investing.com

Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer

GlobeNewswire Inc.

Korro Announces $70 Million Private Placement - citybiz

citybiz

Finanzdaten der Korro Bio Inc.-Aktie (KRRO)

Korro Bio Inc. (KRRO) Nettogewinn 2024

Korro Bio Inc. (KRRO) Free Cashflow 2024

Korro Bio Inc. (KRRO) Gewinn je Aktie 2024